BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium longum {B.Longum } - Clostridium acetobutylicum |
👶
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer. Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 577 Pub: 2016 Epub: 2016 Apr 22 Authors Valdés-Varela L , Alonso-Guervos M , García-Suárez O , Gueimonde M , Ruas-Madiedo P , Html Article Publication |
| bifidobacterium longum {B.Longum } - Clostridium acetobutylicum |
👶
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , Html Article Publication |
| bifidobacterium longum {B.Longum } - Clostridium acetobutylicum |
👶
Different Alterations in Gut Microbiota between Bifidobacterium longum and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism. Nutrients (Nutrients ) Vol: 14 Issue 3 Pages: Pub: 2022 Jan 30 Epub: 2022 Jan 30 Authors Abujamel TS , Al-Otaibi NM , Abuaish S , AlHarbi RH , Assas MB , Alzahrani SA , Alotaibi SM , El-Ansary A , Aabed K , Html Article Publication |
| bifidobacterium longum {B.Longum } - Clostridium acetobutylicum |
👶
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
